IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay $634 million in damages. As the Daily Journal reports, a federal jury agreed ...

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages, Masimo said Friday. “This is a significant ...

A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.

The legal woes of the Apple Watch are continuing, as Apple has been hit with a $634 million verdict in a trial over alleged infringement of Masimo's blood oxygen monitoring patents. Masimo has ...

Apple, and the Apple Watch in particular, were hit with a legal one-two punch Friday. A jury found against the gadget titan, ordering it to pay $634 million to the health tech company Masimo, while on ...

The latest legal slugfest between local medical device maker Masimo Corp. and its nemesis, Apple Inc., began last week in a Santa Ana federal courtroom. In a civil trial before a jury of eight, Masimo ...

Masimo has beat its Q3 revenue estimates by $4.5 million, as several financial analysts double down on the company’s “buy” rating. The company reported third quarter revenues of $371.2M, up 7.6% ...

Good afternoon, ladies and gentlemen, and welcome to the Masimo Third Quarter 2025 Earnings Conference Call. The company's press release is available at www.masimo.com. Thank you. Hello, everyone.